Umeclidinium for symptom relief in COPD: additional benefit is not proven

2 May 2016 - No sighificant differences for moderate disease and no data for severe disease. ...

Read more →

Aclidinium bromide in COPD: evidence of significant additional value in certain patients

15 January 2016 - With reference to new scientific evidence, the manufacturer requested a reassessment and submitted a new dossier. ...

Read more →

Tiotropium/olodaterol in COPD: IQWiG finds disadvantages in patients with more severe disease, advantages for some women

16 November 2015 - According to the findings, there were no statistically significant differences between the treatment groups for the totality ...

Read more →